id
stringlengths
14
22
prompt
listlengths
1
1
completion
listlengths
1
1
Label
stringlengths
1
943
10223244_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** radical retropubic prostatectomy\nbilateral lymphadenectomy\n" } ]
radical retropubic prostatectomy bilateral lymphadenectomy
10223244_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** Allelic imbalance\nallelic loss\nallelic loss\noverall frequency of allelic imbalance\nallelic loss\nallelic loss\nallele\nallelic loss\nallelic loss\nloss of one allele\nfrequency of allelic imbalance\nallelic deletion\n" } ]
Allelic imbalance allelic loss allelic loss overall frequency of allelic imbalance allelic loss allelic loss allele allelic loss allelic loss loss of one allele frequency of allelic imbalance allelic deletion
10224577_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** prosthetic valve thrombosis ( PVT )\n20\nnon-obstructive PVT .\n" } ]
prosthetic valve thrombosis ( PVT ) 20 non-obstructive PVT .
10224577_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** transesophageal echocardiography\nstreptokinase-mediated fibrinolysis ;\nintravenous heparin by infusion .\nheparin\nHeparin\n" } ]
transesophageal echocardiography streptokinase-mediated fibrinolysis ; intravenous heparin by infusion . heparin Heparin
10224577_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** efficacy and safety\nvalve motion\nthrombi\ncomplications\nthrombus size\nstroke\nefficient and safe\nstroke\n" } ]
efficacy and safety valve motion thrombi complications thrombus size stroke efficient and safe stroke
10225743_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** critically ill patients , especially those with severe sepsis .\n" } ]
critically ill patients , especially those with severe sepsis .
10225743_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Blood purification\nblood purifying technologies\npolymyxin B immobilized fiber\ncharcoal hemoperfusion\nplasma or whole blood exchange\npolymyxin B immobilized fiber\n" } ]
Blood purification blood purifying technologies polymyxin B immobilized fiber charcoal hemoperfusion plasma or whole blood exchange polymyxin B immobilized fiber
10225743_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** Blood purification\nefficacy\nindications\nefficacy\n" } ]
Blood purification efficacy indications efficacy
10230191_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** autism\nyoung children\nwith autism .\nTwenty-four\nautism\n" } ]
autism young children with autism . Twenty-four autism
10230191_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Naltrexone\nnaltrexone\nNaltrexone\nplacebo\nvideotaped samples of seminaturalistic parent-child interaction\nnaltrexone\nplacebo\nnaltrexone\n" } ]
Naltrexone naltrexone Naltrexone placebo videotaped samples of seminaturalistic parent-child interaction naltrexone placebo naltrexone
10230191_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** median number of words the child produced\nmedian proportion of utterances with echolalia\nchildren or parents ' communication\nchild 's number of words\ndevelopmental quotient\n" } ]
median number of words the child produced median proportion of utterances with echolalia children or parents ' communication child 's number of words developmental quotient
10235220_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** chronic anti-HBe-positive hepatitis B\nSeventy-two\n59\nmale\n13\nfemale\n41 yr\n" } ]
chronic anti-HBe-positive hepatitis B Seventy-two 59 male 13 female 41 yr
10235220_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** alpha interferon ( IFN )\nIFN\nalpha-N1 IFN i.m .\nalpha-2a IFN i.m .\n2 alpha-2a IFN\n" } ]
alpha interferon ( IFN ) IFN alpha-N1 IFN i.m . alpha-2a IFN i.m . 2 alpha-2a IFN
10235220_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** response rate to alpha interferon ( IFN )\nnormal ALT\nserum HBV-DNA levels\nnormal ALT\nundetectable HBV-DNA\nremission\nrate of long term response\n" } ]
response rate to alpha interferon ( IFN ) normal ALT serum HBV-DNA levels normal ALT undetectable HBV-DNA remission rate of long term response
10337083_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** 360 potential respondents\n90 residents\n" } ]
360 potential respondents 90 residents
10337083_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Postal Group\nTelephone Group\nFace-to-face Group\nmail survey\n" } ]
Postal Group Telephone Group Face-to-face Group mail survey
10337083_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** Effective response rates\neffective response rates\n.\n" } ]
Effective response rates effective response rates .
10337433_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** acute allergic conjunctivitis .\nallergic conjunctivitis .\n" } ]
acute allergic conjunctivitis . allergic conjunctivitis .
10337433_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** olopatadine ophthalmic solution\nketorolac ophthalmic solution\nolopatadine ophthalmic solution\nketorolac ophthalmic solution\nOlopatadine\nKetorolac\nolopatadine\nplacebo\nketorolac\nplacebo\nplacebo\nOlopatadine\nplacebo\nKetorolac\nplacebo\nOlopatadine\nket...
olopatadine ophthalmic solution ketorolac ophthalmic solution olopatadine ophthalmic solution ketorolac ophthalmic solution Olopatadine Ketorolac olopatadine placebo ketorolac placebo placebo Olopatadine placebo Ketorolac placebo Olopatadine ketorolac ketorolac olopatadine ketorolac
10337433_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** efficacy and safety\ngraded ocular itching\nhyperemia in conjunctival , ciliary , and episcleral vessel beds .\nocular itching\nhyperemia\nitching\neffective\nhyperemia\nocular itching\ncomfortable\nocular itching\nhyperemia\n" } ]
efficacy and safety graded ocular itching hyperemia in conjunctival , ciliary , and episcleral vessel beds . ocular itching hyperemia itching effective hyperemia ocular itching comfortable ocular itching hyperemia
10337657_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** prostate cancer\n" } ]
prostate cancer
10337657_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** total androgen ablation\nradical prostatectomy ( RP )\n\" neoadjuvant \" hormonal therapy ( NHT )\ntotal androgen ablation\nradical retropubic prostatectomy and bilateral pelvic node dissection\ntotal androgen ablation\nNHT\ntotal androgen ablation\nneoadjuvant...
total androgen ablation radical prostatectomy ( RP ) " neoadjuvant " hormonal therapy ( NHT ) total androgen ablation radical retropubic prostatectomy and bilateral pelvic node dissection total androgen ablation NHT total androgen ablation neoadjuvant therapy immediate surgery alone total androgen ablation before RP NH...
10337657_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** pathologic stage and resection limit status of prostate cancer\neffect of NHT on pathologic stage of PCa and resection limit status\npathologic stage and resection limit status\npathological stage B\npercentage of cancers with negative margins\nproportion of pa...
pathologic stage and resection limit status of prostate cancer effect of NHT on pathologic stage of PCa and resection limit status pathologic stage and resection limit status pathological stage B percentage of cancers with negative margins proportion of patients with pathological stage B negative margins pathological s...
10337847_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** 77 )\ncognitively impaired\n" } ]
77 ) cognitively impaired
10337847_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Problem-solving counseling\nproblem-solving counseling\nindividualized problem-solving counseling by nurses\nnurse counseling or\nnot\nnurse counseling\ncontrol\ncounseling\ncounseling\ncontrol\nnurse counseling\n" } ]
Problem-solving counseling problem-solving counseling individualized problem-solving counseling by nurses nurse counseling or not nurse counseling control counseling counseling control nurse counseling
10337847_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** relative 's illness\npsychological distress\nburden\ncoping skills\nexpenditures\nimprovement\nrelative 's illness\npsychological distress\ncaregiver burden\npsychological distress\npsychosocial adjustment\npsychosocial adjustment\nhealth and social services\n"...
relative 's illness psychological distress burden coping skills expenditures improvement relative 's illness psychological distress caregiver burden psychological distress psychosocial adjustment psychosocial adjustment health and social services
10338217_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** patients with bone marrow transplantation ( BMT )\npatients undergoing BMT\n66 patients\n43\n23\n21\nPatients with hematologic malignancies\n14\nrelationship to GLN administration .\n1 of 10\n" } ]
patients with bone marrow transplantation ( BMT ) patients undergoing BMT 66 patients 43 23 21 Patients with hematologic malignancies 14 relationship to GLN administration . 1 of 10
10338217_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** glutamine\nTotal parenteral nutrition ( TPN ) supplemented with glutamine ( GLN )\noral GLN\nglycine-control\nTPN\nGLN\nTPN\nGLN\nTPN\nhigh-dose chemotherapy , total body irradiation , and either allogeneic ( ALLO ) BMT\nstem cell transplantation\nAUTO\nGLN\n" ...
glutamine Total parenteral nutrition ( TPN ) supplemented with glutamine ( GLN ) oral GLN glycine-control TPN GLN TPN GLN TPN high-dose chemotherapy , total body irradiation , and either allogeneic ( ALLO ) BMT stem cell transplantation AUTO GLN
10338217_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** hospital stay , duration of stay after BMT , TPN days\nneutrophil recovery > 500/mm3 , incidence of positive blood cultures\nsepsis , mucositis , and diarrhea\nAcute graft us host disease\nimproved long-term survival\n" } ]
hospital stay , duration of stay after BMT , TPN days neutrophil recovery > 500/mm3 , incidence of positive blood cultures sepsis , mucositis , and diarrhea Acute graft us host disease improved long-term survival
10348763_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** children\nmalignant disease :\nchildren\nmalignant disease\n82\nchildren\nmalignant disease\n" } ]
children malignant disease : children malignant disease 82 children malignant disease
10348763_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Amphotericin B\namphotericin B administered in dextrose\nlipid emulsion\namphotericin B ( AmB )\ndextrose\nAmB infused in lipid emulsion\nAmB\nAmB\ndextrose\nAmB\nlipid emulsion\nAmB\nAmB\ndextrose\nAmB infused in lipid emulsion\nAmB\nAmB\ndextrose\nAmB in lipi...
Amphotericin B amphotericin B administered in dextrose lipid emulsion amphotericin B ( AmB ) dextrose AmB infused in lipid emulsion AmB AmB dextrose AmB lipid emulsion AmB AmB dextrose AmB infused in lipid emulsion AmB AmB dextrose AmB in lipid emulsion AmB AmB in dextrose AmB in lipid emulsion AmB in lipid emulsion Am...
10348763_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** pharmacokinetics of AmB\nconcentration of AmB in plasma\nclearance ( CL ) of AmB in dextrose\nsteady-state volume of distribution for AmB\nAmB in lipid emulsion\nAmB in dextrose\nsafety and tolerance\n" } ]
pharmacokinetics of AmB concentration of AmB in plasma clearance ( CL ) of AmB in dextrose steady-state volume of distribution for AmB AmB in lipid emulsion AmB in dextrose safety and tolerance
10352330_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** respiratory distress syndrome\nG-CSF group which received chemotherapy with G-CSF\nhistorical controls without G-CSF\n132\npatients with hematological malignancy in complete remission without any main organ dysfunction who had been treated between April 1983 an...
respiratory distress syndrome G-CSF group which received chemotherapy with G-CSF historical controls without G-CSF 132 patients with hematological malignancy in complete remission without any main organ dysfunction who had been treated between April 1983 and December 1997 . no remarkable difference in the number of pat...
10352330_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** granulocyte/colony-stimulating factor\ngranulocyte/colony-stimulating factor ( G-CSF )\nchemotherapy with G-CSF\nhistorical controls without G-CSF\nG-CSF\nG-CSF\nG-CSF\nG-CSF\nG-CSF\nG-CSF\nG-CSF\n" } ]
granulocyte/colony-stimulating factor granulocyte/colony-stimulating factor ( G-CSF ) chemotherapy with G-CSF historical controls without G-CSF G-CSF G-CSF G-CSF G-CSF G-CSF G-CSF G-CSF
10352330_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** intensity of chemotherapy\nduration of neutropenia\npulmonary infection\npulmonary infection\nincidence of ARDS due to pulmonary infection per chemotherapy session\nincidence of ARDS due to pulmonary infection was higher in the G-CSF group\n" } ]
intensity of chemotherapy duration of neutropenia pulmonary infection pulmonary infection incidence of ARDS due to pulmonary infection per chemotherapy session incidence of ARDS due to pulmonary infection was higher in the G-CSF group
10352397_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** obese\nadults\nobesity\n24\nobese\n22\nwomen\n2\nmen\n22-46 years\nobese\n" } ]
obese adults obesity 24 obese 22 women 2 men 22-46 years obese
10352397_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Low-dose growth hormone treatment with diet restriction\nGrowth hormone\ndiet\nrecombinant human GH\nplacebo\nGH\nGH\nGH injections\nGH\nGH\n" } ]
Low-dose growth hormone treatment with diet restriction Growth hormone diet recombinant human GH placebo GH GH GH injections GH GH
10352397_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** accelerates body fat loss , exerts anabolic effect and improves growth hormone secretory dysfunction\naccelerated lipolysis\nlipolytic effect of GH\ninsulin-like growth factor ( IGF ) -I\nlipolytic and anabolic actions\ninsulin\nGH secretion\nfraction of body w...
accelerates body fat loss , exerts anabolic effect and improves growth hormone secretory dysfunction accelerated lipolysis lipolytic effect of GH insulin-like growth factor ( IGF ) -I lipolytic and anabolic actions insulin GH secretion fraction of body weight lost as fat and a greater loss of visceral fat area lean bod...
10355394_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** cardiac reoperations .\nlow-risk patients who had coronary artery bypass grafting ( CABG )\nThree hundred fifty\nsubgroup\nstudy group\n" } ]
cardiac reoperations . low-risk patients who had coronary artery bypass grafting ( CABG ) Three hundred fifty subgroup study group
10355394_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Duraflo II heparin-coated circuits\nHeparin-coated circuits\nheparin\nheparin-coated circuits\nheparin-coated ( Duraflo II\nuncoated\n" } ]
Duraflo II heparin-coated circuits Heparin-coated circuits heparin heparin-coated circuits heparin-coated ( Duraflo II uncoated
10355394_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** percentage of patients with major bleeding episodes\nvalve reoperations\nblood transfusion requirements\nreoperation for bleeding\n" } ]
percentage of patients with major bleeding episodes valve reoperations blood transfusion requirements reoperation for bleeding
10356632_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** dependent amphetamine\ndependent amphetamine\n19\n10\n10\n9\n" } ]
dependent amphetamine dependent amphetamine 19 10 10 9
10356632_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** auditory selective attention task ( SAT )\n" } ]
auditory selective attention task ( SAT )
10356632_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** event-related potential ( ERP ) indices\nslowed reaction time\nreduced early processing negativity\npeak N1 amplitude\nWechsler Memory Scale Attention/Concentration index\n" } ]
event-related potential ( ERP ) indices slowed reaction time reduced early processing negativity peak N1 amplitude Wechsler Memory Scale Attention/Concentration index
10360656_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** advanced colorectal cancer\nadvanced colorectal carcinoma\nForty-nine\nchemotherapy-naive\n" } ]
advanced colorectal cancer advanced colorectal carcinoma Forty-nine chemotherapy-naive
10360656_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** 5-fluorouracil\nhuman interferon-beta\n5-fluorouracil ( 5-FU ) monotherapy\n5-FU combined with natural human interferon-beta ( IFN-beta )\nIFN-beta\nIFN-3 to 5-FU\n5-FU\n5-FU\nIFN-beta\n" } ]
5-fluorouracil human interferon-beta 5-fluorouracil ( 5-FU ) monotherapy 5-FU combined with natural human interferon-beta ( IFN-beta ) IFN-beta IFN-3 to 5-FU 5-FU 5-FU IFN-beta
10360656_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** efficacy and safety\ndisease progression\nintolerable toxicity\ntumor response\ntime to progression\nsurvival and toxicity\nimproved response rate\ntime to progression\nsurvival time\ntoxicity\nCumulative 5-FU dose\ndisease progression\nFever\ntoxicity\ngrade I...
efficacy and safety disease progression intolerable toxicity tumor response time to progression survival and toxicity improved response rate time to progression survival time toxicity Cumulative 5-FU dose disease progression Fever toxicity grade IV toxicity
10361382_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** during starvation in humans .\nstarving subjects\n28\nnormal\nage 27-35 years\n" } ]
during starvation in humans . starving subjects 28 normal age 27-35 years
10361382_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** pyridostigmine\nnaloxone\nTRH\nplacebo\nplacebos\npyridostigmine\nnaloxone\npyridostigmine and naloxone\nTRH\nplacebo\nTRH plus naloxone\nTRH plus pyridostigmine\nTRH\nnaloxone\npyridostigmine\npyridostigmine\nnaloxone\npyridostigmine\nTRH\n" } ]
pyridostigmine naloxone TRH placebo placebos pyridostigmine naloxone pyridostigmine and naloxone TRH placebo TRH plus naloxone TRH plus pyridostigmine TRH naloxone pyridostigmine pyridostigmine naloxone pyridostigmine TRH
10361382_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** abnormal TSH response to TRH during starvation\nblunted TSH response\nthyrotropin-releasing hormone ( TRH )\nhypothalamic somatostatinergic tone\nabnormal TSH response to TRH\nTSH response to TRH\nserum total and free T4 and T3 levels\n24-hour urinary-free cort...
abnormal TSH response to TRH during starvation blunted TSH response thyrotropin-releasing hormone ( TRH ) hypothalamic somatostatinergic tone abnormal TSH response to TRH TSH response to TRH serum total and free T4 and T3 levels 24-hour urinary-free cortisol levels TRH tests after prolonged starvation TRH-induced TSH r...
10361648_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** coronary artery bypass graft ( CABG ) patients\nTwo hundred sixteen\nmale\nfemale\n" } ]
coronary artery bypass graft ( CABG ) patients Two hundred sixteen male female
10361648_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** videotape information intervention\nexperimental videotapes\none of the two videotapes before discharge from the hospital\nto receive only the standard discharge preparation\nvideotapes\nvideotapes\n" } ]
videotape information intervention experimental videotapes one of the two videotapes before discharge from the hospital to receive only the standard discharge preparation videotapes videotapes
10361648_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** measures of anxiety and self-efficacy\ndietary fat consumption\nactivity level 1 and 3\nself-efficacy for adhering to the recommended low-fat diet\nsignificantly less dietary fat intake 1 month after hospital release\nmoderate exercise at 1 month\nstrenuous exe...
measures of anxiety and self-efficacy dietary fat consumption activity level 1 and 3 self-efficacy for adhering to the recommended low-fat diet significantly less dietary fat intake 1 month after hospital release moderate exercise at 1 month strenuous exercise dietary and exercise compliance
10374155_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** children\nchildhood\ncataract\nchildren\n" } ]
children childhood cataract children
10374155_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Primary capsulectomy , anterior vitrectomy , lensectomy , and posterior chamber lens implantation\nprimary posterior capsulectomy\nanterior vitrectomy\nlensectomy\nposterior chamber intraocular lens ( PC IOL ) implantation\nPrimary posterior capsulectomy\nanter...
Primary capsulectomy , anterior vitrectomy , lensectomy , and posterior chamber lens implantation primary posterior capsulectomy anterior vitrectomy lensectomy posterior chamber intraocular lens ( PC IOL ) implantation Primary posterior capsulectomy anterior vitrectomy posterior capsulectomy anterior vitrectomy lensect...
10374155_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** childhood cataract\nvisual acuity , estimated red reflex , postsurgical inflammatory reaction , corneal clarity , posterior synechias , iris capture , IOL position , capsulectomy size , glaucoma , cystoid macular edema , retinal tear , and postoperative refract...
childhood cataract visual acuity , estimated red reflex , postsurgical inflammatory reaction , corneal clarity , posterior synechias , iris capture , IOL position , capsulectomy size , glaucoma , cystoid macular edema , retinal tear , and postoperative refraction
10379020_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** extremely-low-birth-weight\ninfants\n807\n" } ]
extremely-low-birth-weight infants 807
10379020_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Vitamin A supplementation\nVitamin A supplementation\nsham treatment\nvitamin A\ncontrol group\n" } ]
Vitamin A supplementation Vitamin A supplementation sham treatment vitamin A control group
10379020_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** effectiveness and safety\nbirth weight\ndeath\nchronic lung disease\npotential vitamin A toxicity\nproportion of infants with serum retinol values\n" } ]
effectiveness and safety birth weight death chronic lung disease potential vitamin A toxicity proportion of infants with serum retinol values
10380161_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** exposed to 2.0 ppm nitrogen dioxide\n8\nexposed to 2.0 ppm NO2 and to filtered air for 4 h\nintermittent moderate exercise\n" } ]
exposed to 2.0 ppm nitrogen dioxide 8 exposed to 2.0 ppm NO2 and to filtered air for 4 h intermittent moderate exercise
10380161_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** nitrogen dioxide\nNitrogen dioxide ( NO2 )\nNO2\nNO2\nNO2\nfiltered air\nundergoing intermittent moderate exercise\nBronchoalveolar lavage\nNO2\nNO2-\nnitrogen dioxide\nNO2\n" } ]
nitrogen dioxide Nitrogen dioxide ( NO2 ) NO2 NO2 NO2 filtered air undergoing intermittent moderate exercise Bronchoalveolar lavage NO2 NO2- nitrogen dioxide NO2
10380161_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** NO2 exposure\npolymorphonuclear neutrophils ( PMNs ) , interleukin 6 ( IL-6 ) , IL-8 , alpha1-antitrypsin , and tissue plasminogen activator\nepithelial cells .\ncell numbers or soluble mediators .\nphagocytose unopsonized Candida albicans\nsuperoxide productio...
NO2 exposure polymorphonuclear neutrophils ( PMNs ) , interleukin 6 ( IL-6 ) , IL-8 , alpha1-antitrypsin , and tissue plasminogen activator epithelial cells . cell numbers or soluble mediators . phagocytose unopsonized Candida albicans superoxide production . susceptibility to virus infection
10382082_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** 84 evaluable\nwomen\n89 women\n" } ]
84 evaluable women 89 women
10382082_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** oral contraceptives containing 20 micrograms of ethinyl estradiol .\nlevonorgestrel/ethinyl estradiol\nnorethindrone/ethinyl estradiol\noral contraceptives ( OC ) containing 100 micrograms levonorgestrel ( LNG ) /20 micrograms ethinyl estradiol ( EE ) ( Aless/L...
oral contraceptives containing 20 micrograms of ethinyl estradiol . levonorgestrel/ethinyl estradiol norethindrone/ethinyl estradiol oral contraceptives ( OC ) containing 100 micrograms levonorgestrel ( LNG ) /20 micrograms ethinyl estradiol ( EE ) ( Aless/Loette ) 1000 micrograms norethindrone acetate ( NETA ) /20 mic...
10382082_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** percentage of normal menstrual cycles\nrate of intermenstrual bleeding and amenorrhea\namenorrheic\noccurrence of bleeding and/or spotting\nadverse events\n" } ]
percentage of normal menstrual cycles rate of intermenstrual bleeding and amenorrhea amenorrheic occurrence of bleeding and/or spotting adverse events
10382134_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** autistic children .\n" } ]
autistic children .
10382134_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** questionnaires .\nquestionnaires\nactigraphy .\n72 hours actigraphy .\nquestionnaires\nactigraphic\n" } ]
questionnaires . questionnaires actigraphy . 72 hours actigraphy . questionnaires actigraphic
10382134_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** Sleep patterns\nSleep disturbances\nearlier morning awakening time\nmultiple and early night arousals\nearlier morning arousal time\nsleep patterns\nsleep disturbances\n" } ]
Sleep patterns Sleep disturbances earlier morning awakening time multiple and early night arousals earlier morning arousal time sleep patterns sleep disturbances
10385063_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** patients with cirrhosis of the liver .\n76 patients\n26\nmen\n50\nwomen\nmen\ntwo groups\nwomen\npatients with cirrhosis of the liver\n" } ]
patients with cirrhosis of the liver . 76 patients 26 men 50 women men two groups women patients with cirrhosis of the liver
10385063_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Calcitriol\ncalcitriol ( 1alpha,25-dihydroxyvitamin D3 )\ncalcitriol\nmeasured by dual-energy X-ray absorptiometry at least twice , 12-57 months apart\n" } ]
Calcitriol calcitriol ( 1alpha,25-dihydroxyvitamin D3 ) calcitriol measured by dual-energy X-ray absorptiometry at least twice , 12-57 months apart
10385063_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** osteoporosis\neffects\nbone mineral density ( BMD )\nBMD of the lumbar vertebrae\ndual-energy X-ray absorptiometry\nchange in BMD\nannual change in BMD\nchange in BMD\nBMD\nbone loss\n" } ]
osteoporosis effects bone mineral density ( BMD ) BMD of the lumbar vertebrae dual-energy X-ray absorptiometry change in BMD annual change in BMD change in BMD BMD bone loss
10390407_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** asthmatic\nasthmatic\nasthmatic\n" } ]
asthmatic asthmatic asthmatic
10390407_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** formoterol\nsalmeterol\nS-potassium , heart rate corrected Q-T interval ( Q-Tc ) , and tremor score were followed as measures of systemic effects\nFormoterol\nmethacholine responsiveness ( 4.6 doubling doses after 120 micrograms )\n" } ]
formoterol salmeterol S-potassium , heart rate corrected Q-T interval ( Q-Tc ) , and tremor score were followed as measures of systemic effects Formoterol methacholine responsiveness ( 4.6 doubling doses after 120 micrograms )
10390407_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** efficacy\nbeta2-adrenoceptor tolerance\nS-potassium\nheart rate corrected Q-T interval ( Q-Tc )\ntremor score\ntremor score\nS-potassium\n" } ]
efficacy beta2-adrenoceptor tolerance S-potassium heart rate corrected Q-T interval ( Q-Tc ) tremor score tremor score S-potassium
10402369_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** None\n" } ]
None
10402369_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** L-arginine\nL-arginine\nflare-up gonadotrophin-releasing hormone analogue ( GnRHa ) plus elevated pure follicle stimulating hormone ( pFSH )\nflare-up GnRHa plus elevated pFSH plus oral L-arginine\nultrasonographic\nL-arginine\nL-arginine\nL-arginine\n" } ]
L-arginine L-arginine flare-up gonadotrophin-releasing hormone analogue ( GnRHa ) plus elevated pure follicle stimulating hormone ( pFSH ) flare-up GnRHa plus elevated pFSH plus oral L-arginine ultrasonographic L-arginine L-arginine L-arginine
10402369_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** uterine and follicular Doppler flow\novarian response to gonadotrophin\nlower cancellation rate\n, an increased number of oocytes collected\nembryos transferred\nincreased plasma and follicular fluid concentrations of arginine , citrulline , NO2-/NO3- , and IGF...
uterine and follicular Doppler flow ovarian response to gonadotrophin lower cancellation rate , an increased number of oocytes collected embryos transferred increased plasma and follicular fluid concentrations of arginine , citrulline , NO2-/NO3- , and IGF-1 Significant Doppler flow improvement pregnancies pregnancies ...
10404444_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** general practitioners .\npaediatric\nacute asthma\npaediatric\n" } ]
general practitioners . paediatric acute asthma paediatric
10404444_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** printed information detailing the care the patient received in hospital and the recommended postdischarge care , as well as standardized educational booklets about asthma\nFollow-up appointments\nintervention\n" } ]
printed information detailing the care the patient received in hospital and the recommended postdischarge care , as well as standardized educational booklets about asthma Follow-up appointments intervention
10404444_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** satisfaction with communication with hospital staff\nsatisfied\nbelieved they were more involved after discharge\nunderstanding of their patient 's hospitalisation\nrate of follow-up attendance\napproval of the intervention used\nsatisfaction with the communica...
satisfaction with communication with hospital staff satisfied believed they were more involved after discharge understanding of their patient 's hospitalisation rate of follow-up attendance approval of the intervention used satisfaction with the communication with medical staff
10408075_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** umbilical cord complications ]\nCases with cord complications and controls were paired\n" } ]
umbilical cord complications ] Cases with cord complications and controls were paired
10408075_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** cardiotocography\ncardiotocography\nCardiotocography\n" } ]
cardiotocography cardiotocography Cardiotocography
10408075_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** umbilical cord complications\ncord complications .\nReliability\nsensitivity\nspecificity\nlevel of agreement\nintraobserver variability\ndetection of cord complications .\n" } ]
umbilical cord complications cord complications . Reliability sensitivity specificity level of agreement intraobserver variability detection of cord complications .
10410152_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** nausea , vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia -- a\nacute myeloid leukemia\n" } ]
nausea , vomiting and appetite loss in remission induction chemotherapy of acute myeloid leukemia -- a acute myeloid leukemia
10410152_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** granisetron and methylprednisolone\ngranisetron alone\ngranisetron plus methylprednisolone\ngranisetron alone\ngranisetron\nmethylprednisolone\nGranisetron\n40 micrograms/kg during chemotherapy\nmethylprednisolone\nGranisetron\ngranisetron and methylprednisolon...
granisetron and methylprednisolone granisetron alone granisetron plus methylprednisolone granisetron alone granisetron methylprednisolone Granisetron 40 micrograms/kg during chemotherapy methylprednisolone Granisetron granisetron and methylprednisolone
10410152_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** nausea\nvomiting\nappetite loss\nnausea\nvomiting\nappetite loss\ncomplete inhibition rate of vomiting\ngrade of vomiting\nNausea\nAppetite loss\nnausea\non appetite loss\ninhibitory effect on vomiting\nnausea\nappetite loss\n" } ]
nausea vomiting appetite loss nausea vomiting appetite loss complete inhibition rate of vomiting grade of vomiting Nausea Appetite loss nausea on appetite loss inhibitory effect on vomiting nausea appetite loss
10414756_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** patients with severe chronic heart failure .\npatients with severe chronic heart failure .\n" } ]
patients with severe chronic heart failure . patients with severe chronic heart failure .
10414756_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** Moderate-intensity exercise training\nmoderate-intensity step aerobics training\nmoderate-intensity ( 50 % of peak oxygen uptake ) 12-week training program\nprogressing to 100 minutes per week of step aerobics and 50 minutes per week of cycling\nperform a train...
Moderate-intensity exercise training moderate-intensity step aerobics training moderate-intensity ( 50 % of peak oxygen uptake ) 12-week training program progressing to 100 minutes per week of step aerobics and 50 minutes per week of cycling perform a training program
10414756_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** Peak oxygen uptake\npeak workload\npercent of predicted power ability\npeak oxygen uptake\npeak workload\npercent of predicted power ability\nheart rate\nblood pressure\npeak oxygen uptake\npeak workloads\n" } ]
Peak oxygen uptake peak workload percent of predicted power ability peak oxygen uptake peak workload percent of predicted power ability heart rate blood pressure peak oxygen uptake peak workloads
10424316_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** healthy\nhypertensive\nhealthy\nmales\nyoung\nhealthy\nmen\n" } ]
healthy hypertensive healthy males young healthy men
10424316_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** captopril\nenalapril\nCaptopril\nenalapril\ncaptopril\nenalapril\nelectroencephalogram\nCaptopril\nplacebo\nEnalapril\ncaptopril\nenalapril\ncaptopril\nenalapril\n" } ]
captopril enalapril Captopril enalapril captopril enalapril electroencephalogram Captopril placebo Enalapril captopril enalapril captopril enalapril
10424316_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** electroencephalogram and cognitive performance\ncognitive functions\nquality of life\nelectroencephalogram ( EEG )\ncognitive functions\nsubjective assessments\nEEG\ncognitive functions\nsubjective activity\nsubjective ratings\nsystolic and diastolic blood pres...
electroencephalogram and cognitive performance cognitive functions quality of life electroencephalogram ( EEG ) cognitive functions subjective assessments EEG cognitive functions subjective activity subjective ratings systolic and diastolic blood pressure blood pressure
10429005_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** healthy\nneonates\n10\ninfants\n" } ]
healthy neonates 10 infants
10429005_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** prone position\nInitial sleeping position was assigned randomly\n1 minute before and after 0.4 mL of water was instilled into the oropharynx\n" } ]
prone position Initial sleeping position was assigned randomly 1 minute before and after 0.4 mL of water was instilled into the oropharynx
10429005_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** reflexes and breathing responses\nsleep state ( active and quiet sleep by electroencephalogram , eye movements , breathing , and\nbehavior\n) , cardiorespiratory measurements ( nasal airflow , chest wall movements , heart rate , and oxygen saturation ) , swallo...
reflexes and breathing responses sleep state ( active and quiet sleep by electroencephalogram , eye movements , breathing , and behavior ) , cardiorespiratory measurements ( nasal airflow , chest wall movements , heart rate , and oxygen saturation ) , swallowing , and esophageal activity ( solid state pressure catheter...
10439497_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** None\n" } ]
None
10439497_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** captopril\natenolol\npravastatin combined with life style intervention\nangiotensin converting enzyme inhibitor ( captopril )\nbeta-receptor blocking agent ( atenolol )\ncholesterol reducing drug\nbeta-hydroxy-methylglutaryl-coenzyme A reductase inhibitor prava...
captopril atenolol pravastatin combined with life style intervention angiotensin converting enzyme inhibitor ( captopril ) beta-receptor blocking agent ( atenolol ) cholesterol reducing drug beta-hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin were also encouraged to improve their lifestyle Lifestyle ...
10439497_outcomes
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract outcome-related spans from the abstract.\n\nInclude spans that describe measured endpoints/results concepts, such as:\n- named outcomes/endpoints\n- symptom scores or clinical measures\n- adverse ...
[ { "role": "assistant", "content": "**Answer:** Improvement in lifestyle\nsupplementary treatment with diuretics\n" } ]
Improvement in lifestyle supplementary treatment with diuretics
10439763_participants
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract participant-related spans from the abstract.\n\nInclude spans that describe the patient/population, such as:\n- disease/condition population terms\n- demographic descriptors (for example age/sex g...
[ { "role": "assistant", "content": "**Answer:** 128\nwomen\nundergoing total mastectomy\nundergoing total mastectomy\n" } ]
128 women undergoing total mastectomy undergoing total mastectomy
10439763_interventions
[ { "role": "user", "content": "You are an expert biomedical annotator for PICO span extraction.\n\nTask: extract intervention/comparator-related spans from the abstract.\n\nInclude spans that describe treatment arms or comparators, such as:\n- drug/device/procedure/intervention names\n- comparator/control/pl...
[ { "role": "assistant", "content": "**Answer:** ketamine\nketamine\nketamine 0.15 mg/kg as a 5-mL i.v .\ninjection 5 min before surgery\nisotonic saline 5 mL i.v .\n5 mL i.v . of isotonic saline ,\n0.15 mg/kg i.v . ketamine\nketamine\nketamine\nketamine\nketamine\nKetamine\n" } ]
ketamine ketamine ketamine 0.15 mg/kg as a 5-mL i.v . injection 5 min before surgery isotonic saline 5 mL i.v . 5 mL i.v . of isotonic saline , 0.15 mg/kg i.v . ketamine ketamine ketamine ketamine ketamine Ketamine